Cargando…
Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study
BACKGROUND: GHB dependence is a growing health problem in several western countries, especially the Netherlands. Attempts to stop using GHB are often followed by relapse shortly after successful detoxification. Craving for GHB use and co-morbid psychiatric symptom levels are thought to be the major...
Autores principales: | Kamal, Rama M, Schellekens, Arnt, De Jong, Cornelis AJ, Dijkstra, Boukje AG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424532/ https://www.ncbi.nlm.nih.gov/pubmed/25927622 http://dx.doi.org/10.1186/s12888-015-0471-4 |
Ejemplares similares
-
Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial
por: Beurmanjer, Harmen, et al.
Publicado: (2018) -
Gamma-Hydroxybutyrate (GHB) With-Drawal
por: Everett, Worth
Publicado: (2001) -
Characterization of the GHB Withdrawal Syndrome
por: Wolf, Casper J. H., et al.
Publicado: (2021) -
Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse
por: Tay, Emma, et al.
Publicado: (2022) -
Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review
por: Caputo, Fabio, et al.
Publicado: (2009)